[UNISEM] QoQ Cumulative Quarter Result on 30-Jun-2023 [#2]

Stock
[UNISEM] UNISEM (M) BHD
Announcement Date
27-Jul-2023
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2023
Quarter
30-Jun-2023 [#2]
Profit Trend
QoQ- 242.82%
YoY- -86.83%
Quarter Report
Latest QR
Upcoming QR
UNISEM's Result
UNISEM's Financial Summary
View:
Show?
Cumulative Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 364,767 1,439,686 1,088,893 732,707 354,047 1,781,838 1,328,191 -57.71%
PBT 11,753 100,412 66,003 41,657 13,411 279,680 204,721 -85.09%
Tax -3,289 -20,174 -14,201 -7,869 -3,555 105,681 113,563 -
NP 8,464 80,238 51,802 33,788 9,856 385,361 318,284 -91.07%
-
NP to SH 8,464 80,238 51,802 33,788 9,856 385,361 318,284 -91.07%
-
Tax Rate 27.98% 20.09% 21.52% 18.89% 26.51% -37.79% -55.47% -
Total Cost 356,303 1,359,448 1,037,091 698,919 344,191 1,396,477 1,009,907 -50.03%
-
Net Worth 2,376,226 2,385,098 2,387,034 2,397,680 2,406,068 2,416,392 2,409,940 -0.93%
Dividend
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Div 32,261 129,046 96,784 64,523 32,261 96,784 64,523 -36.97%
Div Payout % 381.16% 160.83% 186.84% 190.96% 327.33% 25.12% 20.27% -
Equity
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Net Worth 2,376,226 2,385,098 2,387,034 2,397,680 2,406,068 2,416,392 2,409,940 -0.93%
NOSH 1,613,079 1,613,079 1,613,079 1,613,079 1,613,079 1,613,079 1,613,079 0.00%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin 2.32% 5.57% 4.76% 4.61% 2.78% 21.63% 23.96% -
ROE 0.36% 3.36% 2.17% 1.41% 0.41% 15.95% 13.21% -
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
RPS 22.61 89.25 67.50 45.42 21.95 110.46 82.34 -57.72%
EPS 0.52 4.97 3.21 2.09 0.61 23.89 19.73 -91.12%
DPS 2.00 8.00 6.00 4.00 2.00 6.00 4.00 -36.97%
NAPS 1.4731 1.4786 1.4798 1.4864 1.4916 1.498 1.494 -0.93%
Adjusted Per Share Value based on latest NOSH - 1,613,079
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
RPS 22.61 89.25 67.50 45.42 21.95 110.46 82.34 -57.72%
EPS 0.52 4.97 3.21 2.09 0.61 23.89 19.73 -91.12%
DPS 2.00 8.00 6.00 4.00 2.00 6.00 4.00 -36.97%
NAPS 1.4731 1.4786 1.4798 1.4864 1.4916 1.498 1.494 -0.93%
Price Multiplier on Financial Quarter End Date
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Date 29/03/24 29/12/23 29/09/23 30/06/23 31/03/23 30/12/22 30/09/22 -
Price 3.85 3.31 3.26 2.99 3.10 2.76 2.60 -
P/RPS 17.03 3.71 4.83 6.58 14.12 2.50 3.16 207.07%
P/EPS 733.74 66.54 101.51 142.75 507.36 11.55 13.18 1354.41%
EY 0.14 1.50 0.99 0.70 0.20 8.66 7.59 -93.00%
DY 0.52 2.42 1.84 1.34 0.65 2.17 1.54 -51.47%
P/NAPS 2.61 2.24 2.20 2.01 2.08 1.84 1.74 31.00%
Price Multiplier on Announcement Date
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Date 26/04/24 27/02/24 26/10/23 27/07/23 27/04/23 23/02/23 27/10/22 -
Price 3.65 3.26 3.10 3.22 2.92 3.13 2.44 -
P/RPS 16.14 3.65 4.59 7.09 13.30 2.83 2.96 209.47%
P/EPS 695.62 65.54 96.53 153.73 477.90 13.10 12.37 1364.21%
EY 0.14 1.53 1.04 0.65 0.21 7.63 8.09 -93.29%
DY 0.55 2.45 1.94 1.24 0.68 1.92 1.64 -51.69%
P/NAPS 2.48 2.20 2.09 2.17 1.96 2.09 1.63 32.25%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment